Chromosome 5q31 contains a cluster of genes involved in immune response, including a 250 kb risk haplotype associated with Crohn's disease (CD) susceptibility. Recently, two functional variants in , encoding the cation transporters OCTN1 and OCTN2, were proposed as causal variants for CD, but with conflicting genetic evidence regarding their contribution. We investigated this locus by resequencing the coding regions of 10 genes in 24 CD cases and deriving a linkage disequilibrium (LD) map of the 27 single nucleotide polymorphisms (SNPs) detected. Ten SNPs representative of the LD groups observed, were tested for CD association. L503F in SLC22A4 was the only nonsynonymous SNP significantly associated with CD (P ¼ 0.003), but was not associated with disease in the absence of other markers of the 250 kb risk haplotype. Two other SNPs, rs11242115 in IRF1 and rs17166050 in RAD50, lying outside the 250 kb risk haplotype, also showed CD association (P ¼ 0.019 and P ¼ 0.0080, respectively). The RAD50 gene contains a locus control region regulating expression of the Th2 cytokine genes at this locus. Other as yet undiscovered SNPs in this region may therefore modulate gene expression and contribute to the risk of CD, and perhaps of other inflammatory phenotypes.
Introduction
Crohn's disease (CD) [MIM266600] is one of two common subtypes of inflammatory bowel disease (IBD), and is characterized by chronic inflammation that can affect any part of the gastrointestinal tract. The prevalence of CD in Western countries is /100 000 and this, together with its clinical course and high morbidity, represents a significant burden to health care. 1 Attempts to localize CD susceptibility genes through genome-wide linkage studies have identified regions of significant linkage on several chromosomes. 2 Subsequent positional cloning and candidate gene studies identified mutations within the CARD15 (NOD2) gene, at a susceptibility locus on chromosome 16 , that were strongly associated with CD. [3] [4] [5] A genomewide search in Canadian families found evidence of linkage to CD on chromosome 5q31. 6 Linkage disequilibrium (LD) mapping of this locus (known as IBD5) identified a 250 kb haplotype containing 11 single nucleotide polymorphisms (SNPs) that were in almost complete LD with each other and were strongly associated with CD, 7 a finding that has since been replicated in several populations. [8] [9] [10] Re-sequencing of the genes within the 250 kb risk haplotype in seven individuals failed to identify the susceptibility gene at the IBD5 locus. 7 High-resolution analysis of the haplotype structure across 5q31 has shown discrete haplotype blocks, each with a limited diversity of between two and four haplotypes. Recombination occurs between blocks but this is modest enough to detect long-range LD among blocks. 11 It has recently been reported that two SNPs within the adjacent SLC22A4 and SLC22A5 genes at the IBD5 locus, which alter the function of the OCTN1 and OCTN2 cation transporters which they encode, are associated with CD. 12 These two SNPs (L503F and G-207C in SLC22A4 and SLC22A5, respectively), which are in strong LD, lie within the IBD5 risk haplotype, and it has been proposed that it is these variants that confer the disease risk for CD rather than other alleles on the existing 250 kb haplotype. However, it remains unclear whether these two genes are the causative genes at the IBD5 locus, as some studies have shown that the variants are not independent of the general risk haplotype at this locus. [13] [14] [15] [16] In addition, mutations within SLC22A5 that have been associated with systemic carnitine deficiency do not show any evidence of gastrointestinal disturbance. 17 It is therefore possible that causal genes or mutations for CD at this locus are yet to be identified. This chromosomal region is also of considerable interest in other inflammatory disorders as it contains a cluster of cytokine genes, and sequence variants within it have been associated with a variety of inflammatory phenotypes. An intronic SNP in a RUNX1 binding site of SLC22A4 is associated with rheumatoid arthritis, 18 variants in the IL4 and IL13 genes are associated with asthma and atopy, 19 and the SLC22A5 promoter SNP is associated with psoriatic arthritis. 20 In view of the potential importance of these findings to the understanding of the pathogenesis of CD and its general relevance to inflammatory phenotypes, we have carried out a comprehensive mutation screen of the coding regions of nine known genes and one hypothetical gene in this region, refined the LD map and tested relevant variants for association with CD. We find evidence of association of variants that are outside the canonical 250 kb risk haplotype with CD, and which are located close to sequence elements that affect expression of cytokine genes.
Results
We initially tested three SNPs that flank the disease risk haplotype defined by Rioux et al. 7 for association with CD in a British case-control sample. The SNPs IGR2011 and IGR3236 are located at opposite ends of the region of association in haplotype blocks 3 and 10 as previously defined by Daly et al.
11 (Figure 1) , and both show moderate association with CD in our sample (P ¼ 0.019 and P ¼ 0.030, respectively), with SNP IGR2063 in block 4 showing the strongest association (P ¼ 0.0009). There was strong LD across the 250 kb risk haplotype as represented by C2063G and G3236T (D 0 ¼ 0.68), in contrast to the Canadian sample in which SNPs across this region were in complete LD. 7 SNPs IGR2063 and IGR2011 are in strong LD with D 0 ¼ 0.95. A test for conditional association, conditioning on the effect of IGR2063, showed that SNP IGR3236 does not significantly refine the disease haplotype; that is, there is no significant difference in the disease odds ratios due to IGR2063 between haplotypes with and without IGR3236.
The observation that the SNP IGR2011, which lies outside the 250 kb risk haplotype, was associated with CD, and was in strong LD with an SNP within the risk haplotype in our British sample, led us to consider whether regions adjacent to the canonical risk haplotype might harbour causal susceptibility variants for CD. We therefore selected the four known genes from the 250 kb risk haplotype (P4HA2, PDLIM4, SLC22A4 and SLC22A5) and the next five genes telomeric to SLC22A5 (IRF1, IL5, RAD50, IL13 and IL4) which include several plausible candidates, for re-sequencing in a panel of 24 unrelated cases of CD. Cases were selected for those with disease onset occurring below age 21 years in view of the association of this locus with early-onset disease, 6 enriched for the disease risk haplotype as defined by IGR2063 (18 homozygotes, six heterozygotes). This panel provides 490% power to detect SNPs with a frequency of 5% or more, as compared to the previous resequencing screen for common variants in six CD cases and two unaffected individuals. 7 We also investigated a hypothetical gene, LOC441108, which is located between SLC22A5 and IRF1. 21 This gene is supported by 39 human expressed sequence tags and three full-length cDNA sequences in GenBank (including the cDNA FLJ46914). It comprises four exons spread over a 66 kb stretch of chromosome 5 (5:131 774 000-131 840 000 in Ensembl v36), taking up most of the 86 kb, which separates the flanking SLC22A5 and IRF1 genes, and is currently annotated as Ensembl known transcript NP_001013739.1. Recognizable orthologous sequences are found in syntenic sites and with good consensus splice signals in the genomes of chimpanzee, rhesus monkey, pig, dog, cow, rat and mouse. The gene is reasonably well conserved at the nucleotide level, particularly in exon 2 where there are two regions showing 90% identity between human and mouse; of note is a 15 bp sequence in the middle of exon 2, which is invariant in all nine species examined. Despite this, there are multiple reading frame shifts between the species, and no conserved open reading frame. The assumption must be that this is a functional RNA that does not encode a protein.
Mutation screening of the coding regions of these 10 genes in our panel of 24 CD cases revealed 27 SNPs. The sequence changes and their potential functional effects are listed in Table 1 , and their locations are shown in Figure 1 . Three SNPs were non-synonymous, including L503F in SLC22A4. There were seven exonic synonymous SNPs, including a rare SNP L514L in exon 10 of RAD50. Twelve SNPs occurred in 5 0 or 3 0 untranslated regions of genes, and five SNPs were intronic. Rs11242115 in the 5 0 UTR of IRF1 was identified as the previously genotyped IGR2011. The TRANSFAC database predicted that seven of these SNPs, including G-207C in SLC22A5 and the RUNX1-binding domain SNP rs3792876, were located in potential regulatory sites. 22 The SNP rs2304081 in intron 6 of SLC22A4 was identified as a potential splice site mutation.
LD was assessed across the SNPs, and pairwise LD coefficients (r 2 ) calculated using Haploview 30 are shown in Figure 2 . Of the 27 SNPs detected, 21 SNPs could be classified into five distinct LD groups according to values of r 2 as described in Patients and methods ( Figure 1 ). The remaining six SNPs (represented as unshaded in Figure 1 ) were not in strong LD with any other SNP and therefore each represents an additional LD group. A maximum of two LD groups were observed for each gene, suggesting a limited diversity of haplotypes, as suggested by the haplotype block structure proposed previously. 11 A representative SNP from each LD group (with the exception of two rare SNPs, RAD50_C1540T and IL5_A117G) was selected to test for association with CD, with a preference for those that might be of functional importance (Table 1 , and Figure 1 ). SNP IGR2011 in IRF1 (5 0 UTR C-184G) had already been typed as representative of haplotype block 3 (see above and Table 2 ). SNPs L503F in SLC22A5 and G-207C in SLC22A5 were in the same LD group but were both genotyped in view of the proposed direct functional role of these SNPs. 12 Therefore, a total of nine additional SNPs were genotyped in the British CD case-control sample. Thus, SNPs representing the observed LD 
No variants were detected in the putative RNA encoding gene LOC441108.
Chromosome 5q31 in Crohn's disease C Onnie et al groups from all the genes in this region, with the exception of IL5 and LOC441108, were tested for association with CD. SNP G-140A in P4HA2 was in complete LD with L503F in SLC22A4 and G-207C in SLC22A5 ( Figure 2) ; only one low-frequency synonymous SNP was detected in IL5, and no SNPs were detected in LOC441108. Allele frequencies are shown in Table 2 . Two SNPs, L503F in SLC22A4 and the common allele of an intronic SNP, rs17166050 in RAD50, showed a significantly increased frequency in CD cases compared to controls (P ¼ 0.003 and P ¼ 0.008, respectively). In addition, a moderately significant association was observed for G-207C in SLC22A5 (P ¼ 0.028), and for the IGR2011 SNP in the 5 0 UTR of IRF1 (P ¼ 0.019). There were no significant differences in allele frequencies between cases and controls for the SNPs representing IL4, IL13, PDLIM4 and P4HA2.
In order to investigate the contribution of the L503F/ G-207C risk haplotype proposed by Peltekova et al. 11 Two SNP haplotype frequencies for these two markers showed that the risk allele C of RAD50_rs17166050 is increased in cases compared to controls only in the presence of the IGR2063G risk allele (RAD50_rs17166050C-IGR2063G: C-G 44.6% in cases versus 35.9% in controls; C-C 38.9% in cases versus 42.0% in controls); thus the RAD60_rs17166050C association appears to be secondary to the 250 kb risk haplotype and results from LD between these SNPs.
Discussion
The association of sequence variants at the IBD5 locus on chromosome 5q31 with CD is strong and well replicated, but there is no general agreement as to the precise identity of the disease susceptibility genes and alleles involved. [13] [14] [15] [16] The original purpose of our study was to fine-map the region of association with CD and to try to identify functional sequence variants that were directly related to pathogenesis. Our analysis of LD across the region is consistent with the model proposed by Daly et al.
11 of discrete blocks characterized by stretches of high LD interspersed with short intervals of LD breakdown and high levels of recombination. However, we did observe decay in LD across the 250 kb IBD5 risk haplotype, in contrast to the finding of almost complete LD described in the Canadian population. 7 The reasons for such differences are unclear but may reflect differences in population growth, admixture or migrationfactors that could all influence LD. 23 Indeed, a recent comparison of LD at this locus in West Africans and Europeans found evidence of long-range LD in the West African sample, which may be indicative of recent positive selection in this population. 24 Importantly, we observed association of SNPs outside the canonical risk haplotype with CD; SNPs rs17166050, located in intron 4 of RAD50, and rs11242115 in 5 0 UTR of IRF1 (IGR_2011) were significantly associated with CD, and are located in blocks 1 and 3, respectively, as defined by Daly et al. 11 The association of the RAD50 SNP with CD appears to be dependent on the presence of the IGR2063 risk allele and may therefore be a result of longrange LD, but it is also possible that the true causal variant or variants lie outside the previously defined 250 kb risk haplotype. Further haplotype-based studies are required to define the limits of the association with CD at this locus. Also, in individuals who were negative for the IBD5 risk haplotype, we did not find a significantly increased frequency of the L503F-G-207C TC haplotype in CD cases versus controls. Our findings are consistent with several very recent studies of the contribution of these variants to CD susceptibility, [13] [14] [15] that do not support a causal role for these variants and are not consistent with the findings of Peltekova et al. 12, 25 Taken together, the weight of current evidence suggests that despite the effect of the L503F and G-207C variants on the function of the cation transporters OCTN1 and OCTN2, 12 they are unlikely to have a direct causal role in the pathogenesis of CD.
In an effort to identify functional sequence variants with a direct role in CD susceptibility, we re-sequenced all four protein-encoding genes that lie within the IBD5 risk haplotype and five genes that lie telomeric to the risk haplotype, given that SNPs in haplotype blocks 1 and 3 of Daly et al.
11 are also associated with CD in 24 unrelated CD patients. These included the functional candidates IL4, IL5 and IL13, which may be involved in the hyperactive immune response observed in CD as well as other chronic inflammatory conditions. Only three non-synonymous SNPs were observed -L503F in SLC22A4
12 (which was not independently associated with CD), and two further SNPs, R144Q in IL13 and G259T in PDLIM4, neither of which was associated with CD. Thus, any causal sequence variants for CD that are located within this region are likely to be silent or noncoding changes that affect the expression of one or more genes at this locus. None of the non-coding SNPs that did show association with CD have any obvious functional significance other than G-207C, which we find to be associated only in the presence of the IBD5 risk haplotype. Interestingly, the IBD5 locus is replete with conserved non-coding sequences that are involved in the regulation of the T H 2 cytokine gene cluster, 26 and detailed sequence analysis of such regions may reveal variants that alter expression of these cytokines. Finally, the detailed characterization of sequence variation and LD relationships at this locus provided in this study may be usefully applied to the genetic analysis of its involvement in other inflammatory disease phenotypes.
Patients and methods

Patient ascertainment
A cohort of unrelated British patients with CD (N ¼ 632) were recruited after ethical review and after obtaining informed consent from Guy's and St Thomas' Hospitals and St Mark's Hospital, UK. The diagnosis of CD was made by established criteria of clinical, radiological and endoscopic analysis and from histology reports. 27 Healthy controls (N ¼ 284) with no reported history of immunological disorders were recruited from the Greater London region to match the recruitment area and ethnicity of CD cases. The ethnicity of both cases and controls was approximately 94% white Caucasian and 6% non-Caucasian; there was no evidence of population stratification in these cohorts in previous case-control studies.
28-31
Mutation screening
We designed primers to amplify the exons and flanking introns of the 10 genes shown in Figure 1 in 24 unrelated CD cases (primers and PCR conditions available on request). Conserved sequences of the hypothetical gene LOC441108 most likely to represent exons were identified by comparing seven different orthologues. The RUNX1 binding site SNP rs3792876 was also sequenced in the same panel of 24 CD cases.
Genotyping
Genotyping was performed using Pyrosequencing and TaqMan platforms. Pyrosequencing primers were designed for IGR2063 (haplotype block 4 as defined by Daly et al. 11 ), rs960757 (IRF1), R144Q (rs20541 -IL13), G259T (rs17165851 -PDLIM4), rs17166050 (RAD50), L503F (rs1050152 -SLC22A4) and rs3792876 (SLC22A4). TaqMan probes and primers are available from ABIassay-on-demand/design for IGR3236 (haplotype block10), IGR2011 (haplotype block 3, rs11242115 (IRF1), rs2070874 (IL4), rs1007602 (PDLIM4) and G-207C (rs17166050 -SLC22A5). Sequence and reaction conditions are available on request. All SNP assays were verified by comparison with the 24 CD samples that had been genotyped by DNA sequencing, and by checking for Hardy-Weinberg equilibrium in the control population. All control genotypes were in Hardy-Weinberg equilibrium, and average genotyping call rates were 95.5%.
Statistical analysis
Tests for Hardy-Weinberg equilibrium and case-control association analyses (difference in allele frequency) were performed using w 32,33 were calculated using Haploview. 34 LD groups were defined such that the LD coefficient r 2 was greater than 0.8 for all pairs of SNPs within a group. SNPs with high values of r 2 will not only be in strong LD but will also be of similar frequency and therefore have equivalent power to detect association. Haplotype frequencies in cases and controls were estimated by an expectation-maximisation algorithm implemented using COCAPHASE, a module of UNPHASED. 35 Significance levels for differences in haplotype frequencies between subgroups were obtained from unconditional logistic regression as previously described 36 and verified using permutation tests with 10 000 replicates. Tests for conditional analyses were carried out using COCA-PHASE, providing a test for equality of odds ratios for haplotypes identical at conditioning loci.
